Literature DB >> 3281026

Quantitative infectivity assay for HIV-1 and-2.

P L Nara1, P J Fischinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3281026     DOI： 10.1038/332469a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  65 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.

Authors:  C Y Kang; P Nara; S Chamat; V Caralli; T Ryskamp; N Haigwood; R Newman; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.

Authors:  Luis M Agosto; Megan K Liszewski; Angela Mexas; Erin Graf; Matthew Pace; Jianqing J Yu; Avinash Bhandoola; Una O'Doherty
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

4.  Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.

Authors:  S H Pincus; K G Messer; P L Nara; W A Blattner; G Colclough; M Reitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.

Authors:  Marine Kanja; Pierre Cappy; Nicolas Levy; Oyndamola Oladosu; Sylvie Schmidt; Paola Rossolillo; Flore Winter; Romain Gasser; Christiane Moog; Marc Ruff; Matteo Negroni; Daniela Lener
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

6.  An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Authors:  Marek Widera; Steffen Erkelenz; Frank Hillebrand; Aikaterini Krikoni; Darius Widera; Wolfgang Kaisers; René Deenen; Michael Gombert; Rafael Dellen; Tanya Pfeiffer; Barbara Kaltschmidt; Carsten Münk; Valerie Bosch; Karl Köhrer; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.

Authors:  Guangshun Wang; Karen M Watson; Alan Peterkofsky; Robert W Buckheit
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

8.  3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.

Authors:  R W Buckheit; J Germany-Decker; K Qualls-Goodwin; B J Bowdon; W M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells.

Authors:  Jihong Dai; Luis M Agosto; Clifford Baytop; Jianqing J Yu; Matthew J Pace; Megan K Liszewski; Una O'Doherty
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.

Authors:  Rebecca A Russell; Michael D Moore; Wei-Shau Hu; Vinay K Pathak
Journal:  Retrovirology       Date:  2009-02-13       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.